2022 IDF Research Grant Program
Congratulations to our 2022 grantees! Learn more about their research.
The Immune Deficiency Foundation (IDF) has a seed grant program to encourage and support patient-oriented research on primary immunodeficiency diseases. The intent of the grant is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management, or diagnosis of people with primary immunodeficiencies (PI). Consideration will also be given to studies that contribute to the body of medical knowledge in PI.
For 2022, there are two paths for grants:
- Investigator-Initiated Grants
- IDF Sponsored Grants in three areas:
- Microbiome & PI
- Quality of Life in PI, leveraging patient-reported outcomes and the patient perspective
- Mining big data to increase opportunities for early diagnosis
During the actual application process, you will be given the opportunity to select either Investigator-Initiated or IDF Sponsored.
The program is open to applicants currently based in the U.S.* and will consist of one-year grants. Award Value: $25,000 - $50,000 (a somewhat higher level of support is available for a few exceptional proposals).
*These grants are not open to Federal Government Agencies or Departments.
The grant submission deadline, February 28, 2022, has passed. Awardees will be announced in April 2022. Thank you to all those who applied.
If you have any questions or concerns with the application process, contact IDFGrant@primaryimmune.org.
IDF Research Committee
Each research proposal is reviewed by IDF’s Research Committee, which recommends funding for the highest scored proposals. The grant review process is based on the peer review system utilized by the National Institutes of Health (NIH). Scoring of grants is done individually by each member of the Research Committee and scores are added together to determine the final ranking of each proposal. Any reviewer with a conflict of interest is excused from voting on a specific proposal. The grant selection process is unbiased and independent; awards are based solely on scientific merit.
More about the IDF Research Grant Program
Since 2013, IDF Walk for Primary Immunodeficiency has raised more than $3 million. Because of the dollars raised by IDF walk teams and their supporters, IDF has established the IDF Research Grant Program, awarding grants to help improve the diagnosis, treatment and quality of life of people living with PI.
Ranging from research on Common Variable Immune Deficiency (CVID), Severe Combined Immune Deficiency (SCID), XMEN and Selective IgA, these researchers are identifying and understanding the underlying issues of these chronic diseases. With research comes better diagnoses, lives and potentially cures for those with PI.
IDF Research Grants provided with support from Bio Products Laboratory (BPL-USA)